Both in Pharmaceuticals
Larimar Therapeutics vs ARS Pharmaceuticals
Over the past year LRMR returned −27.4% and SPRY returned −65.0%; their daily moves had a correlation of 0.15.
LRMR −27.4% SPRY −65.0%Growth of $1, one year, split-adjusted
| Metric | LRMR | SPRY |
|---|---|---|
| Price | $2.76 | $3.05 |
| Market cap | $286.7M | $303.3M |
| Today | +8.66% | 0.00% |
| 1 month | −0.7% | −29.0% |
| 6 months | −33.5% | −67.1% |
| Year to date | −27.6% | −73.8% |
| 1 year | −28.9% | −64.6% |
| Revenue growth (YoY) | — | +114.2% |
| Gross margin | — | 61.8% |
| Net margin | — | −185.2% |
| P/E (TTM) | — | — |
| Price / sales | — | 2.6× |
| Net cash | $156.3M | -$27.8M |
| Dividend yield | — | — |
| Volatility (60d) | 79.5% | 69.9% |
| Short % of float | 23.8% | 40.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).